Teaching residents to prescribe buprenorphine for opioid use disorder: Insights from a community-based residency program

J Subst Abuse Treat. 2022 Jan:132:108621. doi: 10.1016/j.jsat.2021.108621. Epub 2021 Sep 14.

Abstract

Introduction: Despite the impact of the opioid overdose crisis on the United States, few physicians are trained to provide treatment with buprenorphine. While research has described some factors contributing to comfort in providing buprenorphine treatment, more research is needed to identify optimal strategies to produce physicians who prescribe this medication.

Methods: A community-based family medicine residency in Massachusetts sought to improve residents' comfort with prescribing buprenorphine by integrating patients treated with buprenorphine directly into resident continuity clinic panels in addition to existing mandatory didactic teaching.

Results: The program saw a significant increase in buprenorphine prescribing among residency graduates three years after graduation after integration of patients on buprenorphine into resident continuity panels.

Conclusion: Efforts to further increase the number of graduates prescribing buprenorphine nationwide should emphasize supervised management of patients treated with buprenorphine during residency.

Keywords: Addiction education; Medical treatment; Opioid use disorder; Primary care; Residency.

MeSH terms

  • Buprenorphine* / therapeutic use
  • Drug Overdose* / drug therapy
  • Humans
  • Internship and Residency*
  • Opiate Substitution Treatment
  • Opioid-Related Disorders* / drug therapy
  • Physicians*
  • Practice Patterns, Physicians'
  • United States

Substances

  • Buprenorphine